Imprimis Pharma to make cheaper alternative to Retrophin's Thiola
0
(Reuters) - Compounding pharmacy Imprimis Pharmaceuticals Inc said on Wednesday it plans to make a cheaper alternative to Retrophin Inc's kidney stone drug, Thiola.
